Joshua H. Weinberg

Dr. Joshua H. Weinberg

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2019 in Stroke and Vascular Neurology
Verified
Journal Article
Open access
PDF file
ASAhmad Sweid
Ahmad Sweid
BHBatoul Hammoud
Batoul Hammoud
SRSunidhi Ramesh
Sunidhi Ramesh
DWDaniella Wong
Daniella Wong
TATyler D Alexander
Tyler D Alexander
PJPascal Jabbour
Pascal Jabbour
Care for acute ischaemic stroke is one of the most rapidly evolving fields due to the robust outcomes achieved by mechanical thrombectomy. Large vessel occlusion (LVO) accounts for up to 38% of acute ischaemic stroke and comes with devastating outcomes for patients, families and society in the pre-intervention era. A paradigm shift and a breakthrough brought mechanical thrombectomy back into the spotlight for acute ischaemic stroke; this was because five randomised controlled trials from several countries concluded that mechanical thrombectomy for acute stroke offered overwhelming benefits. This review article will present a comprehensive overview of LVO management, techniques and devices used, and the future of stroke therapy. In addition, we review our institution experience of mechanical thrombectomy for posterior and distal circulation occlusion.

4 June 2020 in Neurosurgery
Verified
Journal Article
Closed access
ASAhmad Sweid
Ahmad Sweid
BHBatoul Hammoud
Batoul Hammoud
JWJoshua H. Weinberg
Joshua H. Weinberg
MOMazen Oneissi
Mazen Oneissi
EREytan Raz
Eytan Raz
PJPascal Jabbour
Pascal Jabbour

1 April 2021 in Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
ASAhmad Sweid
Ahmad Sweid
JWJoshua H. Weinberg
Joshua H. Weinberg
RARawad Abbas
Rawad Abbas
KNKareem El Naamani
Kareem El Naamani
STStavropoula Tjoumakaris
Stavropoula Tjoumakaris
PJPascal Jabbour
Pascal Jabbour
OBJECTIVE: External ventricular drain (EVD) placement is a common neurosurgical procedure. While this procedure is simple and effective, infection is a major limiting factor. Factors predictive of infection reported in the literature are not conclusive. The aim of this retrospective, single-center large series was to assess the rate and independent predictors of ventriculostomy-associated infection (VAI). METHODS: The authors performed a retrospective chart review of consecutive patients who underwent EVD placement between January 2012 and January 2018. RESULTS: A total of 389 patients were included in the study. The infection rate was 3.1% (n = 12). Variables that were significantly associated with VAI were EVD replacement (OR 10, p = 0.001), bilateral EVDs (OR 9.2, p = 0.009), duration of EVD placement (OR 1.1, p = 0.011), increased CSF output/day (OR 1.0, p = 0.001), CSF leak (OR 12.9, p = 0.001), and increased length of hospital stay (OR 1.1, p = 0.002). Using multivariate logistic regression, independent predictors of VAI were female sex (OR 7.1, 95% CI 1.1–47.4; p = 0.043), EVD replacement (OR 8.5, 95% CI 1.44–50.72; p = 0.027), increased CSF output/day (OR 1.01, 95% CI 1.0–1.02; p = 0.023), and CSF leak (OR 15.1, 95% CI 2.6–87.1; p = 0.003). CONCLUSIONS: The rate of VAI was 3.1%. Routine CSF collection (every other day or every 3 days) and CSF collection when needed were not associated with VAI. The authors recommend CSF collection when clinically needed rather than routinely.

1 January 2020 in World Neurosurgery
Verified
Journal Article
Closed access
ASAhmad Sweid
Ahmad Sweid
JWJoshua H. Weinberg
Joshua H. Weinberg
VXVivian Xu
Vivian Xu
KSKavya Shivashankar
Kavya Shivashankar
TATyler D. Alexander
Tyler D. Alexander
STStavropoula Tjoumakaris
Stavropoula Tjoumakaris

25 June 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
ASA. Sweid
A. Sweid
BHB. Hammoud
B. Hammoud
JWJoshua H. Weinberg
Joshua H. Weinberg
PTP. Texakalidis
P. Texakalidis
VXV. Xu
V. Xu
PJPascal Jabbour
Pascal Jabbour
BACKGROUND AND PURPOSE: Intra-arterial chemotherapy for retinoblastoma has dramatically altered the natural history of the disease. The remarkable outcomes associated with a high safety profile have pushed the envelope to offer treatment for patients weighing ≤10 kg. The purpose was to determine the efficacy and safety of IAC infusions performed in infants weighing ≤10 kg with intraocular retinoblastoma. MATERIALS AND METHODS: A retrospective chart review was performed for patients diagnosed with retinoblastoma and managed with intra-arterial chemotherapy. RESULTS: The total study cohort included 207 retinoblastoma tumors of 207 eyes in 196 consecutive patients who underwent 658 intra-arterial chemotherapy infusions overall. Of these, patient weights were ≤10 kg in 69 (35.2%) and >10 kg in 127 (64.8%) patients. Comparison (≤10 kg versus >10 kg) revealed that the total number of intra-arterial chemotherapy infusions was 222 versus 436. Periprocedural complications were not significantly different (2 [0.9%] versus 2 [0.5%]; P = .49). Cumulative radiation exposure per eye was significantly lower in infants weighing ≤10 kg (5.0 Gym2 versus 7.7 Gym2; P = .01). Patients weighing ≤10 kg had a greater frequency of complete tumor regression (82.6% versus 60.9%; P = .02). Mean fluoroscopy time was not significantly different (7.5 versus 7.2; P = .71). There was a significant difference in the frequency of enucleation (16 [21.6%] versus 52 [39.1%]; P = .01). Patients weighing ≤10 kg had greater number of aborted procedures (12 [5.4%] versus 7 [1.6%]; P = .01). On multivariate analysis, weight ≤10 kg was not an independent predictor of complications or procedure failure. CONCLUSIONS: Intra-arterial chemotherapy in patients weighing ≤10 kg is a safe and effective treatment.

29 October 2020 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
ASAhmad Sweid
Ahmad Sweid
KNKareem El Naamani
Kareem El Naamani
KSKalyan Chekravarthy Sajja
Kalyan Chekravarthy Sajja
BHBatoul Hammoud
Batoul Hammoud
MKMichael D Knapp
Michael D Knapp
PJPascal Jabbour
Pascal Jabbour
Background Retinoblastoma is the most common primary intraocular malignancy in children. Objective To determine the incidence of ophthalmic artery (OA) occlusion in patients treated with selective ophthalmic artery catheterization (OAC) for chemotherapy infusion for retinoblastoma. Also, to evaluate technical, anatomical, tumorous, and patient-related factors that are predictors of OA occlusion. Methods A retrospective chart review was performed for patients diagnosed with intraocular retinoblastoma and managed with intra-arterial chemotherapy (IAC). Results The total study cohort included 208 retinoblastoma tumors of 208 eyes in 197 consecutive patients who underwent 688 attempted IAC infusions overall with a total of 624 successful OAC infusions. The total incidence of ophthalmic artery thrombosis was 11.1% (23/208). The numbers of successful OAC procedures before diagnosing OA occlusion were one OAC in six cases (27.3%), two in seven cases (31.8%), three in four cases (18.2%), four in one case (4.5%), five in two cases (9.1%), and six in one case (4.5%). Conclusions Local factors relating to the chemotherapy and selective microcatheterization of the OA are essential factors in the development of OA thrombosis, as seen by the association of OA thrombosis with the frequency of IAC.